Home / Inspections / 1323506

FDA Inspection 1323506 — Shore Institute For Reproductive Medicine, P.C.

Shore Institute For Reproductive Medicine, P.C. — FEI 3003945094

The FDA completed an inspection of Shore Institute For Reproductive Medicine, P.C. on June 22, 2026 in Lakewood, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 22, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Lakewood, NJ (United States)

Facility

Other inspections at this facility

  • 1181540 (NAI Thu Oct 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1108884 (NAI Thu Oct 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1030558 (NAI Fri Oct 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 947439 (NAI Wed Nov 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 882856 (NAI Wed Jun 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources